IGF2BP2 and esophageal squamous cell carcinoma: Our research uncovered that the IGF2BP2-mediated circRUNX1/miR-449b-5p/FOXP3 axis was involved in the pathogenesis and progression of ESCC, providing a novel diagnostic marker and therapeutic target for ESCC patients.